How many institutional investors hold RVMD?

4 tracked institutional investors disclosed a position in RVMD (REVOLUTION MEDICINES INC) in their most recent 13F filing.

Who is the largest institutional holder of RVMD?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in RVMD, valued at $115M.

Where does this RVMD ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

RVMD — REVOLUTION MEDICINES INC

Name: REVOLUTION MEDICINES INC (RVMD) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About REVOLUTION MEDICINES INC (RVMD)

REVOLUTION MEDICINES INC (RVMD) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $115M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in RVMD

100

/100

Strong Institutional Accumulation

Added / Increased1

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track RVMD

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

RVMD Ownership Composition

How REVOLUTION MEDICINES INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

100% of tracked value

Institutions

tracked investors

Total Reported

$165.3M

combined 13F value

Other99.8%
Hedge Funds0.2%

Other(3)

99.8%

Hedge Funds(1)

0.2%

Tracked investors reporting RVMD

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	1M	$97.7M	0.02%	Mar 31, 2026
Izzy Englander	Millennium Management	377.3K	$36.7M	0.02%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	2.6K	$252.9K	0.00%	Mar 31, 2026
Stanley Druckenmiller	Duquesne Family Office	315.9K	$30.7M	0.91%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1M
Value
$97.7M
% Portfolio
0.02%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
377.3K
Value
$36.7M
% Portfolio
0.02%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
2.6K
Value
$252.9K
% Portfolio
0.00%
Stanley DruckenmillerMar 31, 2026
Duquesne Family Office
Shares
315.9K
Value
$30.7M
% Portfolio
0.91%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Stanley Druckenmiller	New	—	$30.7M	May 15, 2026

Stanley Druckenmiller
New
$30.7MMay 15, 2026

Frequently asked questions

How many institutional investors hold RVMD?: 4 tracked institutional investors disclosed a position in RVMD (REVOLUTION MEDICINES INC) in their most recent 13F filing.
Who is the largest institutional holder of RVMD?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in RVMD, valued at $115M.
Did institutional ownership of RVMD increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited RVMD.
Where does this RVMD ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.